Office of Research & Development |
|
Project Number: | I01BX004497-01A2 |
Title: | CCN5 Therapy for Triple Negative Breast Cancer |
Principal Investigator: | Sushanta K. Banerjee |
Location: | Kansas City, MO |
Congressional District Code: | 5 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | October 2019 - March 2024 |
FY 2024 Funding Amount: | $80,000 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |